Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Reddit Inc (RDDT) vs TG Therapeutics Inc (TGTX) Price & Performance

Reddit IncTrade
TG Therapeutics IncTrade

Price performance (Past 24H)

Key statistics

Reddit Inc vs TG Therapeutics Inc — how do they compare? Reddit Inc trades at $147.49 (market cap $28.74B), while TG Therapeutics Inc trades at $54.77 (market cap $8.53B). The key difference: Reddit Inc is far larger — about 3.4× TG Therapeutics Inc's market cap, and TG Therapeutics Inc is trading nearer its 52-week high, Reddit Inc nearer its low. Which is the better fit depends on your goals.

RDDTTGTX
Market Cap
$28.74B$8.53B
Sector
MediaHealth
52-Week High
$270.71$59.06
52-Week Low
$121.84$26.94
Enterprise Value
$25.97B$8.74B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Reddit Inc

Reddit (RDDT) trades at $149.38, down 3.29% amid bearish technical signals, though fundamentals remain strong with 61% YoY revenue growth and consistent earnings beats. The stock faces valuation concerns despite robust profitability margins above 30% and positive analyst sentiment with 64% buy ratings. Recent CEO stock sales and AI licensing renewal risks have contributed to recent volatility.

The outlook remains positive with a $216.08 consensus price target suggesting 45% upside potential, driven by AI monetization and international expansion. Key risks include valuation compression, competitive pressures in digital advertising, and the expiration of major AI data licensing agreements in 2027.

TG Therapeutics Inc

TG Therapeutics (TGTX) trades at $55.74, down 0.44% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $64.00. The company reported strong revenue growth, with Q2 2026 revenue reaching $240 million and full-year 2026 guidance raised to approximately $950 million, though recent quarterly EPS results have missed expectations. News highlights include conference participation and institutional buying interest, supporting positive sentiment.

The outlook remains optimistic driven by Briumvi's commercial growth and pipeline catalysts, but risks include earnings volatility, competitive pressures, and reliance on a key product. Upside potential exists if execution meets raised guidance, making it a focus for growth-oriented investors despite near-term profit misses.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Reddit Inc

Reddit Inc. operates a vast network of online communities organized around various interests, known as 'subreddits'. Functioning as a hybrid of a social media platform and a discussion forum, the company generates revenue primarily through advertising and premium subscriptions. Reddit is a major hub for user-generated content, trending news, and viral discussions, and it is a key player in the digital advertising and social media landscape.

Read more on RDDT

About TG Therapeutics Inc

TG Therapeutics is a fully integrated biopharmaceutical company focused on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases. Its cornerstone product, BRIUMVI (ublituximab-xiiy), is a glycoengineered monoclonal antibody approved for relapsing forms of multiple sclerosis. The company is currently executing a 'pipeline-in-a-product' strategy, expanding BRIUMVI into new delivery methods and indications while advancing a broader portfolio of autoimmune and oncology candidates.

Read more on TGTX